Patents by Inventor Frank Erdmann

Frank Erdmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclosporin derivatives
    Patent number: 9453051
    Abstract: The present invention relates to novel cyclosporin derivatives that do not cross the cellular membrane. The compounds according to the invention are used in medicine, more particularly in the treatment/diagnosis of acute and chronic inflammatory diseases, viral infections, cancer, degenerative muscle diseases, neurodegenerative diseases and damage that is associated with calcium homeostasis impairment. The novel cyclosporin derivatives additionally have no immunosuppressive effect.
    Type: Grant
    Filed: August 29, 2012
    Date of Patent: September 27, 2016
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Lead Discovery Center GmbH
    Inventors: Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kuhling, Michael Bukrinsky, Stephanie Constant, Gerd Ruhter, Peter Nussbaumer, Klaus Dinkel
  • CYCLOSPORIN DERIVATIVES
    Publication number: 20140316104
    Abstract: The present invention relates to novel cyclosporin derivatives that do not cross the cellular membrane. The compounds according to the invention are used in medicine, more particularly in the treatment/diagnosis of acute and chronic inflammatory diseases, viral infections, cancer, degenerative muscle diseases, neurodegenerative diseases and damage that is associated with calcium homeostasis impairment. The novel cyclosporin derivatives additionally have no immunosuppressive effect.
    Type: Application
    Filed: August 29, 2012
    Publication date: October 23, 2014
    Applicants: LEAD DISCOVER CENTER GMBH, MAX-PLANCK-GUSELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kuhling, Michael Bukrinsky, Stephanie Constant, Gerd Ruhter, Peter Nussbaumer, Klaus Dinkel
  • Cyclosporin derivatives
    Patent number: 8618065
    Abstract: A cyclosporin derivative of general Formula (I) or a pharmaceutically compatible salt thereof, which have a pharmaceutical effectiveness, for example in the case of chronic inflammatory diseases. The cyclosporin derivatives are preferably free from a peptide section capable of passing through the membrane of a biological cell.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: December 31, 2013
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V.
    Inventors: Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kühling, Michael Bukrinsky, Stephanie Constant
  • Cyclosporin Derivatives
    Publication number: 20120196749
    Abstract: A cyclosporin derivative of general Formula (I) or a pharmaceutically compatible salt thereof, which have a pharmaceutical effectiveness, for example in the case of chronic inflammatory diseases. The cyclosporin derivatives are preferably free from a peptide section capable of passing through the membrane of a biological cell.
    Type: Application
    Filed: February 15, 2012
    Publication date: August 2, 2012
    Inventors: Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kühling, Michael Bukrinsky, Stephanie Constant
  • ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION
    Publication number: 20120058932
    Abstract: The present invention relates to an active ingredient-peptide construct for extracellular concentration, a process for the concentration of active ingredients in an extracellular space of a multicellular object, the use of the active ingredient-peptide construct according to the invention for the production of a medicinal product and a pharmaceutical composition containing the active ingredient-peptide construct according to the invention.
    Type: Application
    Filed: December 4, 2009
    Publication date: March 8, 2012
    Applicant: MAX PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kühling, Michael Ilya Bukrinsky, Stephanie Constant
  • Device for determining and/or monitoring a process variable
    Patent number: 6954717
    Abstract: The invention relates to a device for determining and/or monitoring a process variable. The aim of the invention is to provide a cost-effective, user-friendly device for determining and/or monitoring a process variable. The inventive device comprises the following elements: a sensor, a measuring/regulating/control unit which pre-defines at least one event to be determined or monitored, and at least one memory unit which stores data according to the at least one pre-defined event. The sensor, the measuring/regulating/control unit and the memory unit form a compact unit or an independent field appliance.
    Type: Grant
    Filed: October 20, 2001
    Date of Patent: October 11, 2005
    Assignee: Endress + Hauser GmbH + Co. KG
    Inventors: Matthias Boldt, Frank Erdmann, Klaus Pankratz, Bert Von Stein, Dietmar Spanke
  • Device for determining and/or monitoring a process variable
    Publication number: 20040030532
    Abstract: The invention relates to a device for determining and/or monitoring a process variable. The aim of the invention is to provide a cost-effective, user-friendly device for determining and/or monitoring a process variable. The inventive device comprises the following elements: a sensor, a measuring/regulating/control unit (3) which pre-defines at least one event to be determined or monitored, and at least one memory unit (4; 5) which stores data according to the at least one pre-defined event. The sensor, the measuring/regulating/control unit (3) and the memory unit (4; 5) form a compact unit or an independent field appliance.
    Type: Application
    Filed: August 20, 2003
    Publication date: February 12, 2004
    Inventors: Matthias Boldt, Frank Erdmann, Klaus Pankratz, Bert Von Stein, Dietmar Spanke